Steris (STE) Land & Improvements (2025 - 2026)
Steris (STE) posted quarterly Land & Improvements of $112.3 million for Q1 2026, up 5.84% year-over-year from $106.1 million in Q1 2025, and up 5.84% quarter-over-quarter from $106.1 million in Q1 2025.
Steris (STE) Land & Improvements (2025 - 2026) Analysis & Trends
Steris' Land & Improvements history runs 2 years deep, the most recent figure standing at $112.3 million for Q1 2026.
- In Q1 2026, Land & Improvements rose 5.84% year-over-year to $112.3 million; the TTM figure through Mar 2026 stood at $112.3 million (up 5.84% YoY), while the FY2026 annual figure was $112.3 million, up 5.84% from the prior year.
- Land & Improvements for Q1 2026 stood at $112.3 million, up from $106.1 million in the prior quarter.
- The five-year high for Land & Improvements was $112.3 million in Q1 2026, with the low at $106.1 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.18 Bn | 122.71 Bn | 4.50 Bn | 1.81 Bn |
| 3 | Medtronic | 118.63 Bn | 109.41 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.75 Bn | 72.21 Bn | 3.85 Bn | 183.00 Mn |
| 5 | Edwards Lifesciences | 52.10 Bn | 47.85 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.68 Bn | 31.57 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.32 Bn | 23.00 Bn | 4.55 Bn | - |
| 9 | Steris | 23.10 Bn | 22.62 Bn | 684.20 Mn | 112.50 Mn |
| 10 | Zimmer Biomet Holdings | 19.10 Bn | 18.69 Bn | 1.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 112.50 Mn |
| Mar 31, 2026 | 112.30 Mn |
| Mar 31, 2025 | 106.10 Mn |